UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia

Neurology, 2014-12, Vol.83 (23), p.2153-2157

2014

Volltextzugriff (PDF)

Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies

Therapeutic Advances in Neurological Disorders, 2016-07, Vol.9 (4), p.336-343

2016

Volltextzugriff (PDF)

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

Therapeutic Advances in Neurological Disorders, 2021, Vol.14, p.17562864211039648-17562864211039648

2021

Volltextzugriff (PDF)

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses

JAMA neurology, 2013-03, Vol.70 (3), p.390

2013

Volltextzugriff (PDF)

Vestibular hypofunction after monosodium glutamate ingestion: broadening the spectrum of ‘Chinese restaurant syndrome’

Journal of neurology, 2016-05, Vol.263 (5), p.1027-1028

2016

Volltextzugriff (PDF)

Thymic epithelium determines a spontaneous chronic neuritis in Icam1(tm1Jcgr)NOD mice

The Journal of immunology (1950), 2014-09, Vol.193 (6), p.2678-2690

2014

Volltextzugriff (PDF)

Relapse-independent multiple sclerosis progression under natalizumab

Brain communications, 2021, Vol.3 (4), p.fcab229-fcab229

2021

Volltextzugriff (PDF)

Immunomodulatory treatment strategies in multiple sclerosis

Journal of neurology, 2008-12, Vol.255 (Suppl 6), p.15-21

2008

Volltextzugriff (PDF)

Cladribine as a therapeutic option in multiple sclerosis

Clinical immunology (Orlando, Fla.), 2012-01, Vol.142 (1), p.68-75

2012

Volltextzugriff (PDF)

Thymic Epithelium Determines a Spontaneous Chronic Neuritis in Icam1tm1JcgrNOD Mice

The Journal of immunology (1950), 2014-09, Vol.193 (6), p.2678-2690

2014

Volltextzugriff (PDF)

Infectious risk stratification in multiple sclerosis patients receiving immunotherapy

Annals of clinical and translational neurology, 2017-12, Vol.4 (12), p.909-914

2017

Volltextzugriff (PDF)

Correlation of fingolimod induced lymphopenia and physical measures in MS patients

JOURNAL OF NEUROIMMUNOLOGY, 2014, Vol.275 (1), p.216-217

2014

Volltextzugriff (PDF)

Long-term B-lymphocyte depletion with rituximab in patients with relapsing-remitting multiple sclerosis

Archives of neurology (Chicago), 2009-02, Vol.66 (2), p.259

2009

Volltextzugriff (PDF)

High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes

Archives of neurology (Chicago), 2001-01, Vol.58 (1), p.91

2001

Volltextzugriff (PDF)

Thymic Epithelium Determines a Spontaneous Chronic Neuritis in Icam1 tm1Jcgr NOD Mice

The Journal of immunology (1950), 2014-09, Vol.193 (6), p.2678-2690

2014

Volltextzugriff (PDF)

Cladribine as a therapeutic option in multiple sclerosis: Immune Mechanisms of New Therapeutic Strategies in Multiple Sclerosis

Clinical immunology (Orlando, Fla.), 2012, Vol.142 (1), p.68-75

2012

Volltextzugriff (PDF)

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab: Evidence for disease heterogeneity

Journal of neurology, 2008-09, Vol.255 (9), p.1436-1438

2008

Volltextzugriff (PDF)

Type III systemic allergic reaction to natalizumab

Archives of neurology (Chicago), 2008-06, Vol.65 (6), p.851

2008

Volltextzugriff (PDF)

Ambulante spezialfachärztliche Versorgung (ASV) für die multiple Sklerose: Positionspapier der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) auf der Basis gegenwärtiger Versorgungsdefizite und -hürden („white paper“)

DGNeurologie, 2023-11, Vol.6 (6), p.481-492

2023

Volltextzugriff (PDF)

Immunomodulation in multiple sclerosis

Hot topics in neurology and psychiatry, 2011

2011

Volltextzugriff (PDF)

Multiple sclerosis: current and prospective therapies

Hot topics in neurology and psychiatry, 2011

2011

Volltextzugriff (PDF)

Vestibular hypofunction after monosodium glutamate ingestion: broadening the spectrum of 'Chinese restaurant syndrome'

Journal of neurology, 2016, Vol.263 (5), p.1027-1028

2016

Volltextzugriff (PDF)

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab. Evidence for disease heterogeneity

Journal of neurology, 2008, Vol.255 (9), p.1436-1438

2008

Volltextzugriff (PDF)

Case of alopecia universalis associated with alemtuzumab treatment in MS

Neurology : neuroimmunology & neuroinflammation, 2018-05, Vol.5 (3)

2018

Volltextzugriff (PDF)

Aspects of nutrition for prevention and treatment of chronic neurological diseases

Nervenarzt, 2019-08, Vol.90 (8), p.843

Leussink, Verena Isabell

2019

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(33)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia

Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses

Vestibular hypofunction after monosodium glutamate ingestion: broadening the spectrum of ‘Chinese restaurant syndrome’

Thymic epithelium determines a spontaneous chronic neuritis in Icam1(tm1Jcgr)NOD mice

Relapse-independent multiple sclerosis progression under natalizumab

Immunomodulatory treatment strategies in multiple sclerosis

Cladribine as a therapeutic option in multiple sclerosis

Thymic Epithelium Determines a Spontaneous Chronic Neuritis in Icam1tm1JcgrNOD Mice

Infectious risk stratification in multiple sclerosis patients receiving immunotherapy

Correlation of fingolimod induced lymphopenia and physical measures in MS patients

Long-term B-lymphocyte depletion with rituximab in patients with relapsing-remitting multiple sclerosis

High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes

Thymic Epithelium Determines a Spontaneous Chronic Neuritis in Icam1 tm1Jcgr NOD Mice

Cladribine as a therapeutic option in multiple sclerosis: Immune Mechanisms of New Therapeutic Strategies in Multiple Sclerosis

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab: Evidence for disease heterogeneity

Type III systemic allergic reaction to natalizumab

Ambulante spezialfachärztliche Versorgung (ASV) für die multiple Sklerose: Positionspapier der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) auf der Basis gegenwärtiger Versorgungsdefizite und -hürden („white paper“)

Immunomodulation in multiple sclerosis

Multiple sclerosis: current and prospective therapies

Vestibular hypofunction after monosodium glutamate ingestion: broadening the spectrum of 'Chinese restaurant syndrome'

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab. Evidence for disease heterogeneity

Case of alopecia universalis associated with alemtuzumab treatment in MS

Aspects of nutrition for prevention and treatment of chronic neurological diseases

Suchergebnisse filtern